Health Canada inspection
McGill University Health Centre (MUHC) - Stem Cell Transplant & Immune Effector Cell Therapy Program: Health Canada inspection of Feb 12, 2024
Health Canada · rating C
Key facts
| Establishment | McGill University Health Centre (MUHC) - Stem Cell Transplant & Immune Effector Cell Therapy Program |
|---|---|
| City | Montréal |
| Province | Quebec |
| Country | Canada |
| Start date | Feb 12, 2024 |
| Rating | C |
| Rating description | Compliant |
At a glance
- 1–9 Inspections of this establishment
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.